Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccines

Infection and Immunity

Volumn 67, Issue 8, 1999, Pages 4064-4071

  Ausiello, Clara M ^a   Lande, Roberto ^a   Urbani, Francesca ^a   La Sala, Andrea ^a   Stefanelli, Paola ^a   Salmaso, Stefania ^a   Mastrantonio, Paola ^a   Cassone, Antonio ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BORDETELLA PERTUSSIS; CELL PROLIFERATION; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INFANT; MALE; PERTUSSIS; PRIORITY JOURNAL; SEROCONVERSION; VACCINATION;

EID: 0032769217     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.8.4064-4071.1999     Document Type: Article

References (36)

1. Ad Hoc Group for the Study of Pertussis Vaccines. 1998. Placebo controlled trial of two acellular pertussis vaccines in Sweden; protective efficacy and adverse events. Lancet ii:955-960.
2. Ausiello, C. M., F. Urbani, S. Gessani, G. C. Spagnoli, M. J. Gomez, and A. Cassone. 1993. Cytokine gene expression in human peripheral blood mononuclear cells stimulated by mannoprotein constituents of Candida albicans. Infect. Immun. 61:4905-4911.
3. Ausiello, C. M., A. la Sala, C. Ramoni, F. Urbani, A. Funaro, and F. Malavasi. 1996. Secretion of IFN-γ, IL-6, granulocyte-macrophage colony-stimulating factor and IL-10 cytokines after activation of human purified T lymphocytes upon CD38 ligation. Cell. Immun. 173:192-197.
4. Ausiello, C. M., F. Urbani, A. la Sala, R. Lande, and A. Cassone. 1997. Vaccine and antigen-dependent type 1 and type 2 cytokine induction in children after primary vaccination with whole-cell or acellular pertussis vaccines. Infect. Immun. 65:2168-2174.
5. Ausiello, C. M., R. Lande, A. la Sala, F. Urbani, and A. Cassone. 1998. Cell-mediated immune response of healthy adults to B. pertussis vaccine antigens. J. Infect. Dis. 178:466-470.
6. Barenkamp, S. J., and E. Leininger. 1992. Cloning, expression, and DNA sequence analysis of genes encoding nontypeable Haemophilus influenzae high-molecular-weight surface-exposed proteins related to filamentous hemagglutinin of Bordetella pertussis. Infect. Immun. 60:1302-1313.
7. Cassone, A., C. M. Ausiello, F. Urbani, A. IaSala, R. Lande, A. Piscitelli, M. Giuliano, S. Salmaso, and The Progetto Pertosse-CMI Working Group. 1997. Cell-mediated and antibody responses to B. pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. Arch. Pediatr. Adolesc. Med. 151:283-289.
8. Cherry, J. D. 1997. Comparative efficacy of acellular pertussis vaccines: an analysis of recent trials. Pediatr. Infect. Dis. J. S90-S96.
9. Cherry, J. D., J. Gornbein, U. Heininger, and K. Stehr. 1998. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 15:1901-1906.
10. Edwards, K. M., B. D. Meade, M. D. Decker, G. F. Reed, M. B. Rennels, M. C. Steinhoff, E. L. Anderson, J. A. Enguland, M. E. Pichichero, and M. A. Deloria. 1995. Comparison of thirteen acellular pertussis vaccines: overview and serological response. Pediatrics 96:548-557.
11. Giuliano, M., P. Mastrantonio, A. Giammanco, A. Piscitelli, S. Salmaso, and S. G. F. Wassilak. 1998. Antibody responses and persistence in the 2 years following immunization with two acellular and one whole-cell vaccines against pertussis. J. Pediatr. 132:973-978.
12. Greco, D., S. Salmaso, P. Mastrantonio, M. Giuliano, A. G. Tozzi, A. Anemona, M. L. Ciofi Degli Atti, A. Giammanco, P. Panei, W. C. Blackwelder, D. L. Klein, S. G. F. Wassilak, and the Progetto Pertosse Working Group. 1996. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N. Engl. J. Med. 334:341-348.
13. He, Q., N. N. T. Minh, K. Edelman, M. K. Viljanen, H. Arvilommi, and J. Mertsola. 1998. Cytokine mRNA expression and proliferative responses induced by pertussis toxin, filamentous hemagglutinin, and pertactin of Bordetella pertussis in the peripheral blood mononuclear cells of infected and immunized schoolchildren and adults. Infect. Immun. 66:3796-3801.
14. He, Q., M. K. Viljanen, H. Arvilommi, B. Aittanen, and J. Mertsola. 1998. Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunized population. JAMA 280:635-637.
15. Hewlett, E. L. 1997. Pertussis: current concepts of pathogenesis and prevention. Pediatr. Infect. Dis. J. S78-S84.
16. Isacson, J., B. Trollfors, J. Taranger, and T. Lagergard. 1995. Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis. Pediatr. Infect. Dis. J. 14:517-521.
17. Levy-Bruhl, D., R. Pebody, I. Veldhuijzen, M. Valenciano, and K. Osborne. 1998. ESEN: a comparison of vaccination programmes - part 2: pertussis. Eurosurv. Weekly 3:107-110.
18. Mahon, B. P., B. J. Sheanhan, F. Griffin, G. Murphy, and K. H. G. Mills. 1997. Atypical disease after B. pertussis respiratory infection of mice with targeted disruptions of interferon-γ receptor or immunoglobulin μ chain genes. J. Exp. Med. 186:1843-1851.
19. Mastrantonio, P., P. Stefanelli, M. Giuliano, Y. Herrera Rojas, M. Ciofi degli Atti, A. Anemona, and A. E. Tozzi. 1998. Bordetella parapertussis infection in children: epidemiology, clinical symptoms, and molecular characteristics of isolates. J. Clin. Microbiol. 36:999-1002.
20. Mc Guirk, P., B. P. Mahon, F. Griffin, and K. H. G. Mills. 1998. Compartmentalization of T cell responses following respiratory infection with B. pertussis: hyporesponsiveness of lung T cells is associated with modulated expression of the co-stimulatory molecule CD28. Eur. J. Immunol. 28:153-163.
21. Medical Research Council. 1956. Vaccination against whooping cough: relation between protection in children and results of laboratory tests. Br. Med. J. 2:454-462.
22. Miller, E., L. A. E. Ashworth, R. Redhead, C. Thornton, P. A. Waight, and T. Coleman. 1997. Effect of schedule on reactogenicity and antibody persistence of acellular and whole-cell pertussis vaccines: value of laboratory tests as predictors of clinical performance. Vaccine 15:51-60.
23. Mills, K. H. G., M. Ryan, E. Ryan, and B. P. Mahon. 1998. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against B. pertussis. Infect. Immun. 66:594-602.
24. Mooi, F. R., H. G. J. van der Heide, A. R. TerAvest, K. G. Welinder, I. Livey, B. M. A. van der Zeisj, and V. Gaastra. 1987. Characterization of fimbrial subunits from Bordetella species. Microb. Pathog. 3:1-8.
25. Pichichero, M. E. 1993. Pertussis and the pertussis vaccines. Curr. Opin. Infect. Dis. 6:558-564.
26. Redhead, K., J. Watkins, A. Barnard, and K. H. G. Mills. 1993. Effective immunization against B. pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect. Immun. 61:3190-3198.
27. Rota, M. C., C. M. Ausiello, R. D'Amelio, A. Cassone, A. Giammanco, C. Molica, R. Lande, D. Greco, and S. Salmaso. 1998. Prevalence of markers of exposure to Bordetella pertussis among Italian young adults. Clin. Infect. Dis. 26:297-302.
28. Ryan, M., G. Murphy, L. Gothefors, L. Nilsson, J. Storsaeter, and K. H. G. Mills. 1997. Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J. Infect. Dis. 175:1246-1250.
29. Ryan, M., G. Murphy, L. Nilsson, F. Shackley, L. Gothefors, K. Omar, E. Miller, J. Storsaeter, and K. H. G. Mills. 1998. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology 93:1-10.
30. Salmaso, S., P. Mastrantonio, S. G. F. Wassilak, M. Giuliano, A. Anemona, A. Giammanco, A. E. Tozzi, M. L. Ciofi degli Atti, D. Greco, and the Stage II Working Group. 1998. Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines. Vaccine 16:1270-1275.
31. Salmaso, S., A. E. Tozzi, and M. L. Ciofi degli Atti. Observer bias in acellular pertussis vaccine trials. Pediatrics, in press.
32. Storsaeter, J., W. C. Blackwelder, and H. O. Hallander. 1992. Pertussis antibodies, protection, and vaccine efficacy after household exposure. Am. J. Dis. Child 146:167-172.
33. Storsaeter, J., H. O. Hallander, L. Gustafsson, and P. Olin. 1998. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 16:1907-1916.
34. Tran Minh, N. N., K. Edelman, Q. He, M. K. Viljanen, H. Arvilommi, and J. Mertsola. 1998. Antibody and cell-mediated immune responses to booster immunization with a new acellular pertussis vaccine in school children. Vaccine 16:1604-1610.
35. Weinberg, A., L. Zhang, and D. Brown. 1999. Effect of cryopreservation on cell-mediated immunity assay, abstr. 450, p. 152. In Abstracts of the 6th Conference on Retroviruses and Opportunistic Infections.
36. Zepp, F., M. Knuf, P. Habermehl, H. J. Schimitt, C. Rebsch, P. Schmidtke, R. Clements, and M. Slaoui. 1996. Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine. Infect. Immun. 64:4078-4084.